| Year | Title | Author(s) |
| 2021 |
Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
Genes |
Xuan, JC Gitareja, K Brajanovski, N Sanij, E |
| 2021 |
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Signal Transduction And Targeted Therapy |
Kang, J Brajanovski, N Chan, KT Xuan, JC Pearson, RB Sanij, E |
| 2021 |
The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function
Nature Cell Biology |
Koltowska, K Okuda, KS Gloger, M Rondon-Galeano, M Mason, E Xuan, JC Dudczig, S Chen, HJ Arnold, H Skoczylas, R Bower, NI Paterson, S Lagendijk, AK Baillie, GJ Leshchiner, I Simons, C Smith, KA Goessling, W Heath, JK Pearson, RB Sanij, E Schulte-Merker, S Hogan, BM |
| 2020 |
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Nature Communications |
Sanij, E Hannan, KM Xuan, JC Yan, SF Ahern, JE Trigos, AS Brajanovski, N Son, J Chan, KT Kondrashova, O Lieschke, E Wakefield, MJ Frank, D Ellis, S Cullinane, C Kang, J Poortinga, G Nag, P Deans, AJ Khanna, KK Mileshkin, L McArthur, GA Soong, J Berns, EMJJ Hannan, RD Scott, CL Sheppard, KE Pearson, RB |